Investigators estimated the incidence of HBsAg seroclearance in patients with hepatitis B virus infection on long-term therapy with entecavir or tenofovir disoproxil fumarate.
While the risk is small, there have been 20 cases of unexpected donor-derived hepatitis B virus infection
Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.
Eligible patients more likely to complete HCV screening if order is included with reminder
Vaxelis is the first hexavalent combination vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.
The finding of a reduce risk of cirrhosis in patients with chronic HBV on antiviral therapy underscores the importance of early treatment.
Investigators analyzed the safety of tenofovir disoproxil fumarate therapy during the third trimester of pregnancy.
Researchers aimed to characterize serological, virological, and histological profiles during and after multidose ARC-520 treatment in patients with chronic HBV.
Researchers assessed the influence of direct-acting antivirals on gut microbiota by analyzing microbial diversity and composition in patients with hepatitis C virus infection with or without HIV.
Demand increased for inpatient consults, inpatient endoscopic interventions for alcohol-related GI, liver diseases, particularly alcoholic hepatitis
Black patients have better liver function at the time of hepatocellular carcinoma diagnosis.
Studies have demonstrated an association between direct-acting antiviral therapy and a reduction in both the incidence and severity of extrahepatic manifestations of HCV.
Patients with current or past HBV infection are not at greater risk for liver injury or mortality during COVID-19 infection.
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
The CIRRhosis Using Standard tests algorithm could use results of routine blood tests to identify patients at high risk for advanced liver disease
There is a need for interventions to increase HCC surveillance in patients with cirrhosis due to a high proportion of late-stage detection.
Researchers aimed to estimate the prevalence of liver fibrosis and factors associated with it in people living with HIV compared with those in a control group.
The ACIP emphasizes the importance of routine vaccinations during the pandemic to prevent diseases.
By conducting prospective studies of liver function test abnormalities at baseline, a team of researchers hoped to elucidate the clinical relevance of liver injury in patients with COVID-19.
Researchers in a real-world clinical practice study assessed the incidence of weight loss and weight regain in patients with NAFLD and overweight or obesity.